Practice-Changing Lung Cancer Data From WCLC and ESMO 2021
This episode of Thoracic Night Live focuses on findings that have read out in lung cancer from some recent medical meetings, including the 2021 World Conference on Lung Cancer and 2021 ESMO Congress.
Funding from Daiichi Sankyo/Content Independently Developed by OncLive
EP. 1: Adjuvant Immunotherapy Breakthroughs in Lung Cancer from ESMO 2021
October 27th 2021Isabel Preeshagul, DO, MBS; Catherine Ann Shu, MD; and Ashish Saxena, MD, PhD, discuss breakthroughs in adjuvant immunotherapy in lung cancer from data presented at the 2021 ESMO Congress and 2021 World Conference on Lung Cancer.
EP. 2: Neoadjuvant and Stage IV Immunotherapy Data Shaking Up Lung Cancer Paradigm
October 27th 2021Isabel Preeshagul, DO, MBS; Catherine Ann Shu, MD; and Ashish Saxena, MD, PhD, highlight results with immunotherapy in the neoadjuvant and stage IV setting in lung cancer that were presented at the 2021 World Conference on Lung Cancer and the 2021 ESMO Congress.
EP. 3: Living In a Targeted Therapy Revolution of NSCLC
October 27th 2021Isabel Preeshagul, DO, MBS; Catherine Ann Shu, MD; and Ashish Saxena, MD, PhD, share insight on the data with novel targeted agents with impressive efficacy in patients with lung cancer, as seen at the 2021 ESMO Congress and the 2021 World Conference on Lung Cancer.
EP. 4: It’s Not a Small World for Small Cell Lung Cancer Treatment
October 27th 2021Isabel Preeshagul, DO, MBS; Catherine Ann Shu, MD; and Ashish Saxena, MD, PhD, discuss the latest findings in small cell lung cancer based on studies that were presented during the 2021 ESMO Congress, 2021 World Conference on Lung Cancer, and 2021 ASCO Annual Meeting.
